FIELD: medicine.
SUBSTANCE: method comprises dressing the upper third of the left coronary artery and administering the Alloplant biopreparation into the stenosed artery circulation. The administration is carried out by intramyocardial injection of 3.0 mg of a biopreparation diluted in physiological saline. Injections are performed immediately after stenosing the artery at 6 points, by 0.5 mg each.
EFFECT: effective stimulation of endogenous mechanisms of myocardial regeneration, preventing postinfarction cardiac remodeling.
2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTING TREATMENT TACTICS FOR TREATING PATIENTS FOR MYOCARDIAL INFARCTION AGGRAVATED WITH VENTRICULAR RHYTHM DISORDERS | 2004 |
|
RU2267984C1 |
AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
METHOD FOR TREATING VENTRICULAR EXTRASYSTOLE THE CASES OF MYOCARDIAL INFARCTION | 2000 |
|
RU2197241C2 |
METHOD OF TREATING PATIENTS WITH MYOCARDIAL INFARCTION | 2007 |
|
RU2381795C2 |
METHOD FOR DETERMINING INDICATIONS TO SURGICAL TREATMENT OF CARDIAC ISCHEMIA PATIENTS SURVIVED AFTER MYOCARDIAL INFARCTION | 2004 |
|
RU2269934C1 |
METHOD FOR TREATING A PATIENT WITH A LARGE-FOCUS MYOCARDIAL INFARCTION | 1998 |
|
RU2197230C2 |
METHOD FOR PREDICTING THE OCCASIONAL ACUTE MYOCARDIAL INFARCTION WITHIN THE FIVE YEARS OF THE POST-INFARCT PERIOD | 2017 |
|
RU2645626C1 |
METHOD FOR DIAGNOSIS OF POSTINFARCTION INFLAMMATION IN MYOCARDIUM ASSOCIATED WITH UNFAVORABLE CARDIAC REMODELING | 2019 |
|
RU2714694C1 |
METHOD OF DETECTING RISK GROUP OF DIASTOLIC AORTIC VENTRICLE DYSFUNCTION IN PATIENTS SUFFERING FROM CORONARY HEART DISEASE | 2007 |
|
RU2356499C1 |
TRANSLATIONAL MODEL OF CHRONIC HEART FAILURE: THE METHOD AND CRITERIA OF FORMATION ASSESSMENT | 2018 |
|
RU2744681C1 |
Authors
Dates
2017-10-26—Published
2016-04-18—Filed